List of works by Luciano Mutti

A Polysome-Based microRNA Screen Identifies miR-24-3p as a Novel Promigratory miRNA in Mesothelioma

scientific article published on 02 August 2018

A common polymorphism within MSLN affects miR-611 binding site and soluble mesothelin levels in healthy people.

scientific article

Anti-CTLA-4 therapy for malignant mesothelioma

scientific article published on March 2017

Clinical Significance of Serum Mesothelin in Patients with Mesothelioma and Lung Cancer

scientific article published on 01 September 2007

Comparison between Plasma and Serum Osteopontin Levels: Usefulness in Diagnosis of Epithelial Malignant Pleural Mesothelioma

scientific article published on 01 July 2010

Correction: MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma.

scientific article published on 22 June 2017

Correction: P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma

scientific article published on 16 October 2020

Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism

scientific article

ERS Statement on harmonised standards for lung cancer registration and lung cancer services in Europe

scientific article published on 20 December 2018

Expression status of candidate genes in mesothelioma tissues and cell lines.

scientific article

HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis

scientific article published on 25 August 2020

HLA-B*44 and C*01 Prevalence Correlates with Covid19 Spreading across Italy

scientific article published on 23 July 2020

Inhibition of the platelet-derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of mesothelioma cell lines.

scientific article

Insight into glucocorticoid receptor signalling through interactome model analysis.

scientific article published on 6 November 2017

MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma.

scientific article published on 21 January 2014

Mesothelin promoter variants are associated with increased soluble mesothelin-related peptide levels in asbestos-exposed individuals.

scientific article published on 25 March 2017

P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma

scientific article published on 14 September 2020

Protein disulfide isomerase A1 regulates breast cancer cell immunorecognition in a manner dependent on redox state

scientific article published on 20 October 2020

Repurposing atovaquone: targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells

scientific article published on 30 April 2016

SV40 enhances the risk of malignant mesothelioma among people exposed to asbestos: a molecular epidemiologic case-control study.

scientific article

Scientific Advances and New Frontiers in Mesothelioma Therapeutics

scientific article published on 01 September 2018

Sirtuin Family Members Selectively Regulate Autophagy in Osteosarcoma and Mesothelioma Cells in Response to Cellular Stress

scientific article published on 24 September 2019

Status Determines the Sensitivity of Malignant Mesothelioma Cells to Gemcitabine Treatment

scientific article published on 19 January 2019

Targeting hypoxic response for cancer therapy

scientific article

The Biochemical Role of the Human NEIL1 and NEIL3 DNA Glycosylases on Model DNA Replication Forks

scientific article published on 23 April 2019

The inhibition of FGF receptor 1 activity mediates sorafenib antiproliferative effects in human malignant pleural mesothelioma tumor-initiating cells

scientific article published on 25 May 2017

Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: an open-label, single-arm, phase 2 trial

scientific article published on 11 September 2013

Tremelimumab for the treatment of malignant mesothelioma

scientific article

What can independent research for mesothelioma achieve to treat this orphan disease?

scientific article published on 01 July 2019

When RON MET TAM in Mesothelioma: All Druggable for One, and One Drug for All?

scientific article published on 26 February 2019

p53 modeling as a route to mesothelioma patients stratification and novel therapeutic identification

article